Fauci-Funded Wuhan Lab Collaborator Peter Daszak STILL Getting Millions from U.S. Govt to Play with NEW Bat Viruses


by Jack Montgomery, The National Pulse:

Peter Daszak, the Anthony Fauci-funded researcher whose EcoHealth Alliance group is accused of having potentially been involved in the creation of COVID-19 before it leaked from a Wuhan laboratory, is still receiving millions of dollars from the U.S. government, and still seeking out viruses in bats, pangolins, and other animals around the world with which to experiment.

Americans have pumped $20 million into EcoHealth Alliance since 2020, records reveal, to fund projects expected to run until August 2027, despite Donald Trump’s efforts to pull its funding and end its potentially dangerous virus projects before Joe Biden became President.

TRUTH LIVES on at https://sgtreport.tv/

The group’s activities extend well beyond China, with projects involving bat viruses in the likes of Burma (Myanmar), Laos, and the Philippines underway. They have already found at least one hitherto unknown bat virus in Thailand, capable of infecting human tissue “almost as well” as COVID-19.

“The U.S. taxpayer is funding recklessness,” warned Rutgers University virologist Dr. Richard Ebright.

“EcoHealth Alliance is currently receiving $50 million in NIH [National Institute of Health] and Department of Defense grants for the same types of reckless research that likely caused the present pandemic.”

Daszak became an infamous figure following the COVID-19 outbreak, not just for his group’s alleged involvement in causing it, but for working vigorously to deny the Chinese Communist Party (CCP) had been involved in covering up the initial outbreak of the Wuhan virus, and its true origin. The CCP, for its part, pushed hard for Daszak to be given a prominent role as a pandemic investigator at the United Nations.

Fauci, who also attempted to squash allegations that a lab leak caused the Covid pandemic, has appeared at conferences sponsored by Daszak’s group.

Read More @ TheNationalPulse.com